Cited by 7Smoking Behavior and CessationSubstance Abuse Treatment and OutcomesHealth Systems, Economic Evaluations, Quality of Life

The Potential Impact of Widespread Cessation Treatment for Smokers With Depression

Open access
Tam, Jamie, Warner, Kenneth E., Zivin, Kara, Taylor, Gemma M.J., Meza, Rafael·2021·American Journal of Preventive Medicine

Abstract

Introduction Experts recommend integrating smoking-cessation treatments within U.S. mental health settings, but the population health benefits of doing so have not been estimated. This study simulates the impact of widespread cessation treatment for patients with depression under best-case treatment and maximum potential cessation scenarios.Methods Cessation interventions were simulated for U.S. adult smokers seeing a health professional for depression from 2020 to 2100. Interventions included (1) Any Treatment (behavioral counseling, pharmacological, combination) and (2) Pharmacological Treatment (including counseling), combined with increased mental health service utilization each. These were compared with a maximum potential cessation scenario where all patients with major depression quit smoking. Analyses were conducted in 2016-2020.Results Widespread uptake of Any Treatment among patients with depression would avert 32,000 deaths and result in 138,000 life-years gained by 2100; Any Treatment combined with 100% mental health service utilization would result in 53,000 and 231,000, respectively. Pharmacological Treatment would avert 125,000 deaths, with 540,000 life-years gained. Pharmacological Treatment combined with 100% mental health service utilization would result in 203,000 deaths averted and 887,000 life-years gained. Health gains under best-case treatment scenarios represent modest fractions of those projected under maximum potential cessation scenarios at current mental health service utilization levels (835,000 deaths averted, 3.73 million life-years gained) and at 100% utilization (1.11 million deaths averted, 5.07 million life years gained).Conclusions Providing smoking-cessation treatment to patients with depression and increasing mental health service utilization would reduce the toll of tobacco on this population. These gains would be considerably larger if cessation treatments were more effective.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.amepre.2021.04.024

Cites

38 of 38 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 2

  1. [18]Center for Behavioral Health Statistics and Quality. Impact of the DSM-IV to DSM-5 Changes on the National Survey on Drug Use and Health. Rockville, MD: Substance Abuse and Mental Health Services Administration; 2016. 30199183
  2. [21]Tam J, Taylor G, Zivin K, Warner KE, Meza R. Modeling smoking-attributable mortality among adults with major depression in the United States. Prev Med. 2020; 140: 106241. 10.1016/j.ypmed.2020.106241. 32860820 PMC7680404 · DOI

Cited by

Sorted by citations

Authors
Tam, J., Warner, K. E., Zivin, K., Taylor, G. M. J., & Meza, R.
Affiliations
  • Yale University (US)
  • University of Michigan (US)
  • University of Bath (GB)
Corresponding author
Tam, Jamie
Venue
American Journal of Preventive Medicine
Publisher
Elsevier BV
Published
2021-11
Volume
61
Issue
5
Pages
674-682
ISSN
0749-3797 (ISSN-L)
OpenAlex
W3177516548
Cited by
7
References
38
Citations by year
2026: 1 · 2025: 1 · 2023: 2 · 2022: 3
FWCI
0.78
Type
journal article
Language
en
Open access
Locations
  • American Journal of Preventive Medicine (publishedVersion)
  • PubMed (publishedVersion)
  • Bristol Research (University of Bristol) (publishedVersion)
  • PubMed Central (acceptedVersion)
  • Pure (University of Bath) (submittedVersion, cc-by-nc-nd)
Funders
  • University of Michigan
  • National Institutes of Health
  • Cancer Research UK (C56067/A21330)
  • National Institute of Mental Health (R01MH120124)
  • University of Bath
  • National Institute on Drug Abuse (F31DA041083)
  • Health Services Research and Development (VA IIR 17-324a)
  • National Cancer Institute (U01CA199284, U54CA229974)
Topics
  • Health Sciences › Medicine › Physiology › Smoking Behavior and Cessation
  • Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
  • Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Health Systems, Economic Evaluations, Quality of Life
Keywords
smoking cessation, depression, major depressive disorder, tobacco use, mental health service utilization, population health impact, life-years gained, mortality averted, pharmacological smoking cessation, behavioral counseling, integrated care
MeSH terms
Smokers, Adult, Depression, Humans, Smoking, Smoking Cessation, Tobacco Use Cessation Devices

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review